No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
LIVN240719P60000
- 4.10
- 0.000.00%
15min DelayClose May 22 14:09 ET
0.00High0.00Low
4.10Open4.10Pre Close0 Volume3 Open Interest60.00Strike Price0.00Turnover69.47%IV-3.58%PremiumJul 19, 2024Expiry Date6.03Intrinsic Value100Multiplier3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9412Delta0.0345Gamma8.85Leverage Ratio-0.0477Theta-0.0036Rho-8.33Eff Leverage0.0061Vega
Intraday
- 5D
- Daily
News
The Top Growth Stocks, Ranked by Seeking Alpha Analyst Ratings
Further Weakness as LivaNova (NASDAQ:LIVN) Drops 5.3% This Week, Taking Three-year Losses to 37%
For many investors, the main point of stock picking is to generate higher returns than the overall market. But its virtually certain that sometimes you will buy stocks that fall short of the market
Mizhuo's Top Picks in Healthcare for July
LivaNova (NASDAQ:LIVN) Is Doing The Right Things To Multiply Its Share Price
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a business will show two trends; firstly a growing return on capital employed (ROCE) an
LivaNova to Announce Second-Quarter 2024 Results
Jefferies Maintains LivaNova(LIVN.US) With Buy Rating, Maintains Target Price $90
Jefferies analyst Matthew Taylor maintains $LivaNova(LIVN.US)$ with a buy rating, and maintains the target price at $90.According to TipRanks data, the analyst has a success rate of 60.3% and a total
Comments
LivaNova's share price and revenue have been falling for five years, worrying investors. However, the CEO's modest pay could be a positive. The company's future growth is uncertain.
Investors in LivaNova (NASDAQ:LIVN) Have Unfortunately Lost 45% Over the Last Five Years 1
The company's low P/S, despite strong revenue growth, is tied to weaker future revenue forecasts compared to the industry, deterring investors, which hinders the P/S ratio from increasing. A rise in future revenue is needed to justify a higher P/S ratio.
With a continuous trend of declining ROCE, LivaNova's growth seems doubtful. Under competitive pressures and being a matured enterprise, suggestions lean towards considering other investment options.
Upgrades
• $Banc of California(BANC.US$: Raymond James Upgrades to Outperform from Market Perform - PT $22
• $Cullen/Frost Bankers(CFR.US$: Raymond James Upgrades to Outperform from Market Perform
• $W.W. Grainger(GWW.US$: Wolfe Research Upgrades to Outperform from Peerperform
• $Invitation Homes Inc(INVH.US$: Evercore ISI Upgrades to Outperform from In Line - PT $46 (from $44)
• $PCB Bancorp(PCB.US$: Raymond James Upgrades to Outperform from Market Perfor...
• $Banc of California(BANC.US$: Raymond James Upgrades to Outperform from Market Perform - PT $22
• $Cullen/Frost Bankers(CFR.US$: Raymond James Upgrades to Outperform from Market Perform
• $W.W. Grainger(GWW.US$: Wolfe Research Upgrades to Outperform from Peerperform
• $Invitation Homes Inc(INVH.US$: Evercore ISI Upgrades to Outperform from In Line - PT $46 (from $44)
• $PCB Bancorp(PCB.US$: Raymond James Upgrades to Outperform from Market Perfor...
7
Read more